Found: 95
Select item for more details and to access through your institution.
Survival Prognostication in Patients with Differentiated Thyroid Cancer and Distant Metastases: A SEER Population-Based Study.
- Published in:
- Thyroid, 2024, v. 34, n. 7, p. 837, doi. 10.1089/thy.2023.0709
- By:
- Publication type:
- Article
Real-world treatment patterns and clinical outcomes in patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) treated with first line lenvatinib monotherapy in the United States.
- Published in:
- Endocrine (1355008X), 2024, v. 84, n. 2, p. 663, doi. 10.1007/s12020-023-03638-7
- By:
- Publication type:
- Article
Enhancing precision: A predictive model for <sup>177</sup>Lu-DOTATATE treatment response in neuroendocrine tumors using quantitative <sup>68</sup>Ga-DOTATATE PET and clinicopathological biomarkers.
- Published in:
- Theranostics, 2024, v. 14, n. 9, p. 3708, doi. 10.7150/thno.98053
- By:
- Publication type:
- Article
Comparative Effectiveness of First-Line Selpercatinib versus Standard Therapies in Patients with RET-Activated Cancers: An Exploratory Interpatient Analysis of LIBRETTO-001.
- Published in:
- Cancers, 2024, v. 16, n. 1, p. 140, doi. 10.3390/cancers16010140
- By:
- Publication type:
- Article
Patterns of recurrence in head and neck squamous cell carcinoma to inform personalized surveillance protocols.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 18, p. 2817, doi. 10.1002/cncr.34823
- By:
- Publication type:
- Article
Impact of monoclonal antibody therapy for head and neck cancer on end‐of‐life care utilization and costs.
- Published in:
- Head & Neck, 2023, v. 45, n. 6, p. 1468, doi. 10.1002/hed.27359
- By:
- Publication type:
- Article
Access Denied: Disparities in Thyroid Cancer Clinical Trials.
- Published in:
- Journal of the Endocrine Society, 2023, v. 7, n. 6, p. 1, doi. 10.1210/jendso/bvad064
- By:
- Publication type:
- Article
Tumor immune microenvironment alterations using induction cetuximab in a phase II trial of deintensified therapy for p16‐positive oropharynx cancer.
- Published in:
- Head & Neck, 2023, v. 45, n. 5, p. 1281, doi. 10.1002/hed.27344
- By:
- Publication type:
- Article
Biomarkers predictive of response to pembrolizumab in head and neck cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 6, p. 6603, doi. 10.1002/cam4.5434
- By:
- Publication type:
- Article
Multikinase Inhibitors for the Treatment of Asymptomatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Global Noninterventional Study (RIFTOS MKI).
- Published in:
- Thyroid, 2022, v. 32, n. 9, p. 1059, doi. 10.1089/thy.2022.0061
- By:
- Publication type:
- Article
Randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl‐xL inhibitor.
- Published in:
- Head & Neck, 2022, v. 44, n. 7, p. 1509, doi. 10.1002/hed.27043
- By:
- Publication type:
- Article
A Consideration for Surgical Management in Select T4b Oral Cavity Squamous Cell Carcinoma.
- Published in:
- Annals of Otology, Rhinology & Laryngology, 2022, v. 131, n. 6, p. 609, doi. 10.1177/00034894211038213
- By:
- Publication type:
- Article
Tumor-Infiltrating Lymphocytes in Patients With Advanced Laryngeal Cancer Undergoing Bioselection.
- Published in:
- Otolaryngology-Head & Neck Surgery, 2022, v. 166, n. 3, p. 498, doi. 10.1177/01945998211013765
- By:
- Publication type:
- Article
Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141.
- Published in:
- Oncologist, 2022, v. 27, n. 2, p. e194, doi. 10.1093/oncolo/oyab036
- By:
- Publication type:
- Article
Patient Burden with Current Surveillance Paradigm and Factors Associated with Interest in Altered Surveillance for Early Stage HPV‐Related Oropharyngeal Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 8, p. 676, doi. 10.1002/onco.13784
- By:
- Publication type:
- Article
Vismodegib for Preservation of Visual Function in Patients with Advanced Periocular Basal Cell Carcinoma: The VISORB Trial.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. e1240, doi. 10.1002/onco.13820
- By:
- Publication type:
- Article
Long‐term neck and shoulder function among survivors of oropharyngeal squamous cell carcinoma treated with chemoradiation as assessed with the neck dissection impairment index.
- Published in:
- Head & Neck, 2021, v. 43, n. 5, p. 1621, doi. 10.1002/hed.26636
- By:
- Publication type:
- Article
A Pilot Study of Checkpoint Inhibitors in Solid Organ Transplant Recipients with Metastatic Cutaneous Squamous Cell Carcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 2, p. 133, doi. 10.1002/onco.13539
- By:
- Publication type:
- Article
Efficacy of axitinib in metastatic head and neck cancer with novel radiographic response criteria.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 2, p. 219, doi. 10.1002/cncr.33226
- By:
- Publication type:
- Article
A multi-center phase II trial evaluating the efficacy of palbociclib in combination with carboplatin for the treatment of unresectable recurrent or metastatic head and neck squamous cell carcinoma.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1550, doi. 10.1007/s10637-020-00898-2
- By:
- Publication type:
- Article
Patient Report of Recurrent and Persistent Thyroid Cancer.
- Published in:
- Thyroid, 2020, v. 30, n. 9, p. 1297, doi. 10.1089/thy.2019.0652
- By:
- Publication type:
- Article
Paired phase II trials evaluating cetuximab and radiotherapy for low risk HPV associated oropharyngeal cancer and locoregionally advanced squamous cell carcinoma of the head and neck in patients not eligible for cisplatin.
- Published in:
- Head & Neck, 2020, v. 42, n. 8, p. 1728, doi. 10.1002/hed.26085
- By:
- Publication type:
- Article
A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Predictors of survival in patients undergoing oropharyngeal surgery for cancer recurrence after radiation therapy.
- Published in:
- European Archives of Oto-Rhino-Laryngology, 2020, v. 277, n. 7, p. 2085, doi. 10.1007/s00405-020-05913-z
- By:
- Publication type:
- Article
A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Predictive Values of MRI and PET Derived Quantitative Parameters for Patterns of Failure in Both p16+ and p16– High Risk Head and Neck Cancer.
- Published in:
- Frontiers in Oncology, 2019, v. 9, p. 1, doi. 10.3389/fonc.2019.01118
- By:
- Publication type:
- Article
Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Adjuvant Radiation Improves Recurrence-Free Survival and Overall Survival in Adrenocortical Carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Real-World Treatment Patterns Among Patients Initiating Small Molecule Kinase Inhibitor Therapies for Thyroid Cancer in the United States.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Impact of American Joint Committee on Cancer Eighth Edition clinical stage and smoking history on oncologic outcomes in human papillomavirus‐associated oropharyngeal squamous cell carcinoma.
- Published in:
- Head & Neck, 2019, v. 41, n. 4, p. 857, doi. 10.1002/hed.25336
- By:
- Publication type:
- Article
CheckMate 141: 1‐Year Update and Subgroup Analysis of Nivolumab as First‐Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer.
- Published in:
- Oncologist, 2018, v. 23, n. 9, p. 1079, doi. 10.1634/theoncologist.2017-0674
- By:
- Publication type:
- Article
Low-Cost Intervention to Increase Influenza Vaccination Rate at a Comprehensive Cancer Center.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Capecitabine after Surgical Salvage in Recurrent Squamous Cell Carcinoma of Head and Neck.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Survival Outcomes in Patients with T2N0M0 (Stage II) Squamous Cell Carcinoma of the Larynx.
- Published in:
- Otolaryngology-Head & Neck Surgery, 2017, v. 157, n. 4, p. 625, doi. 10.1177/0194599817711374
- By:
- Publication type:
- Article
Phase II trial of pazopanib in advanced/progressive malignant pheochromocytoma and paraganglioma.
- Published in:
- Endocrine (1355008X), 2017, v. 57, n. 2, p. 220, doi. 10.1007/s12020-017-1359-5
- By:
- Publication type:
- Article
Survival Outcomes in Patients with T2N0M0 (Stage II) Squamous Cell Carcinoma of the Larynx.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Treatment of Advanced Thyroid Cancer in the Age of Novel Targeted Therapies.
- Published in:
- Drugs, 2017, v. 77, n. 7, p. 733, doi. 10.1007/s40265-017-0733-1
- By:
- Publication type:
- Article
Positron emission tomography-CT prediction of occult nodal metastasis in recurrent laryngeal cancer.
- Published in:
- Head & Neck, 2017, v. 39, n. 5, p. 980, doi. 10.1002/hed.24719
- By:
- Publication type:
- Article
Survival Rates Using Individualized Bioselection Treatment Methods in Patients With Advanced Laryngeal Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
ACR appropriateness criteria<sup>®</sup> nasal cavity and paranasal sinus cancers.
- Published in:
- Head & Neck, 2017, v. 39, n. 3, p. 407, doi. 10.1002/hed.24639
- By:
- Publication type:
- Article
Skeletal Complications and Mortality in Thyroid Cancer: A Population-Based Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Feasibility of Non-invasive Brain Modulation for Management of Pain Related to Chemoradiotherapy in Patients with Advanced Head and Neck Cancer.
- Published in:
- Frontiers in Human Neuroscience, 2016, p. 1, doi. 10.3389/fnhum.2016.00466
- By:
- Publication type:
- Article
ACR Appropriateness Criteria<sup>®</sup> Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.
- Published in:
- Head & Neck, 2016, v. 38, n. 9, p. 1299, doi. 10.1002/hed.24447
- By:
- Publication type:
- Article
Classification of TP53 mutations and HPV predict survival in advanced larynx cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Neurologic late effects associated with radiologic evidence of vertebral osteoradionecrosis after salvage laryngectomy: A syndrome associated with survivors of laryngeal and hypopharyngeal cancer.
- Published in:
- Head & Neck, 2016, v. 38, n. 8, p. 1187, doi. 10.1002/hed.24348
- By:
- Publication type:
- Article
ACR Appropriateness criteria® for nasopharyngeal carcinoma.
- Published in:
- Head & Neck, 2016, v. 38, n. 7, p. 979, doi. 10.1002/hed.24423
- By:
- Publication type:
- Article
Patient-Reported Toxic Effects-The Dawn of a New Era.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Matted nodes: High distant-metastasis risk and a potential indication for intensification of systemic therapy in human papillomavirus-related oropharyngeal cancer.
- Published in:
- Head & Neck, 2016, v. 38, p. E805, doi. 10.1002/hed.24105
- By:
- Publication type:
- Article
Maintaining physical activity during head and neck cancer treatment: Results of a pilot controlled trial.
- Published in:
- Head & Neck, 2016, v. 38, p. E1086, doi. 10.1002/hed.24162
- By:
- Publication type:
- Article
Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review.
- Published in:
- Head & Neck, 2016, v. 38, p. E2151, doi. 10.1002/hed.24026
- By:
- Publication type:
- Article